Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price hits fresh 52-week high at Rs 1,979.70
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Ipca Laboratories Share Price is in focus after IPCALAB touched a fresh 52-week high of Rs 1,994 and last traded at Rs 1,979.70, up Rs 4.60 or 0.23% on the day. The company’s market capitalisation stands at Rs 49,491.35 crore, placing the move in a large-value context even as the event remains a fresh one-year high rather than an all-time high. For readers tracking Ipca Laboratories Share Price Today, the confirmed data shows a new yearly high, a narrow gap from the session peak, and a close that remained near that level. Univest is covering the event as part of its stock news flow, with the available data confirming the price milestone but not establishing any company-specific catalyst.
In Ipca Laboratories Share News, the stock’s move is notable because the day’s high matched the 52-week high and the session stayed above the previous close of Rs 1,975.10. The opening was Rs 1,985 and the low was Rs 1,971.80, showing a relatively tight intraday band around the high. On this verified data alone, the event is a fresh 52-week high, and Univest is presenting it as price-action news rather than a narrative about cause or sentiment.
Ipca Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,979.7 |
| Previous Close | Rs 1,975.1 |
| Today's Move | +Rs 4.6 (+0.23%) |
| Open | Rs 1,985 |
| High | Rs 1,994 |
| Low | Rs 1,971.8 |
| Turnover | Rs 1.06 crore |
| Market Capitalisation | Rs 49,491.35 crore |
Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,979.7 versus the previous close of Rs 1,975.1, a rise of 0.23%. The stock opened at Rs 1,985, reached a high of Rs 1,994 and touched a low of Rs 1,971.8.
Ipca Laboratories Share Price Today reflects a session that began at Rs 1,985, moved within a range of Rs 1,971.80 to Rs 1,994, and ended at Rs 1,979.70. The stock added Rs 4.60 from the previous close of Rs 1,975.10, which works out to a 0.23% rise. The day’s high of Rs 1,994 became the fresh 52-week high, so the latest price event is best read as a yearly high being set during the session. Turnover for the day was Rs 1.06 crore, which is the factual traded value available in the dataset. On a pure price basis, this makes the Ipca Laboratories Share Price move a measured upward session rather than a broad, one-sided swing. For readers following Ipca Laboratories Stock News on Univest, the important point is simple: the stock set a new 52-week peak and closed close to that level.
The same price pattern also explains why Ipca Laboratories Share Price Live is drawing attention in Stock Market Today and Share Market Today screens. The stock did not gap excessively away from the prior close, and the session range remained tight around the upper end of the day. That combination keeps the focus on the fresh 52-week high itself, the closing level, and the fact that the move was recorded with a clearly defined turnover figure. The next section places this price event in a valuation and company-quality context.
Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,491.35 crore |
| P/E Ratio | 38.26x |
| P/B Ratio | 5.91x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.3% |
Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 38.26x, P/B 5.91x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.
Ipca Laboratories Ltd. has a market capitalisation of Rs 49491.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.26x, P/B at 5.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.3%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.86x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.26x |
| Benchmark Median P/E | 30.86x |
| Benchmark Average P/E | 48.08x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 5.91x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 49,491.35 crore |
| Benchmark Median Market Cap | Rs 679.12 crore |
Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 38.26x, which is above the benchmark median of 30.86x, a difference of +23.98%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.79%, a difference of +34.69%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.63%, a difference of +42.41%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | ANTHEM | 50,740.53 | 87.21 | 16.05 | 21.98 | 29.62 |
| Gland Pharma Ltd. | GLAND | 47,610.2 | 42.21 | 4.48 | 10.56 | 14.96 |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 52,619.21 | 48.42 | 20.52 | 48.76 | 66.79 |
| Ajanta Pharma Ltd. | AJANTPHARM | 44,472.92 | 39.86 | 9.31 | 25.42 | 32.67 |
| Abbott India Ltd. | ABBOTINDIA | 55,876.53 | 34.03 | 10.61 | 34.67 | 46.72 |
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 38.26x compared with the displayed peer median of 42.21x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 49,491.35 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price touched a fresh 52-week high of Rs 1,994 and last traded at Rs 1,979.70.
- The stock ended Rs 4.60 higher than the previous close, which is a 0.23% rise on the day.
- Market capitalisation stands at Rs 49,491.35 crore, keeping the event within a large-value listed-company context.
- P/E is 38.26 and P/B is 5.91, while EPS is Rs 51.63 and book value per share is Rs 334.38.
- ROE is 15.88% and ROCE is 19.41%, both above the sector benchmark medians in the supplied industry snapshot.
About Ipca Laboratories
Ipca Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data focuses on market capitalisation, financial ratios, and recent financial results, with revenue at Rs 27,881 crore in Jun 2026 and net profit at Rs 4,018.9 crore in the same period. The company’s EPS, book value and dividend yield are also supplied, giving readers a compact profile for Ipca Laboratories Share Price and Ipca Laboratories Company News tracking on Univest. For investors comparing Ipca Laboratories Latest News with other stocks in the Indian Stock Market, the core facts are the listed industry, the valuation metrics and the reported financial performance.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Ipca Laboratories Share Price on Univest for live price updates, fundamental ratios, shareholding pattern views, 52-week levels and market insights. Univest also brings together Ipca Laboratories Stock News, Ipca Laboratories Share Price Live context, sector comparisons and company data in one place for quick reference.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Ipca Laboratories Share Price hit a fresh 52-week high?
Ans. The supplied data confirms that Ipca Laboratories Share Price touched Rs 1,994 during the session, which is the fresh 52-week high. The dataset does not establish a company-specific catalyst for the move.
What is Ipca Laboratories Share Price today?
Ans. Ipca Laboratories Share Price last traded at Rs 1,979.70, up Rs 4.60 or 0.23% from the previous close of Rs 1,975.10. That places the stock close to its intraday high.
What is the 52-week high for Ipca Laboratories?
Ans. The 52-week high for Ipca Laboratories is Rs 1,994, as recorded in the latest session data. The closing price remained close to that level at Rs 1,979.70. The stock moved 0.23% during the session.
How big is Ipca Laboratories in market capitalisation terms?
Ans. Ipca Laboratories has a market capitalisation of Rs 49,491.35 crore. That gives the fresh 52-week high event a substantial listed-company backdrop within the Healthcare sector. The company operates in the Healthcare sector.
How is Ipca Laboratories valued on earnings and book value?
Ans. Ipca Laboratories trades at a P/E of 38.26 and a P/B of 5.91. EPS is Rs 51.63 and book value per share is Rs 334.38, which are the key supplied valuation markers.
How do Ipca Laboratories fundamentals compare with the sector benchmark?
Ans. In the same industry benchmark, Ipca Laboratories’ P/E is above the median of 30.86, while ROE at 15.88% and ROCE at 19.41% are above the median levels of 11.79% and 13.63%.
What do the latest financial results show for Ipca Laboratories?
Ans. The supplied financial data shows revenue of Rs 27,881 crore and net profit of Rs 4,018.9 crore for Jun 2026. Those figures are the latest company financial results included in the dataset.
Where can investors track Ipca Laboratories Share Price on Univest?
Ans. Investors can track Ipca Laboratories Share Price on Univest for live price updates, valuation ratios, shareholding pattern views, 52-week levels and market insights, all organised for quick reference. The stock moved 0.23% during the session.
